Methyldopate hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for methyldopate hydrochloride and what is the scope of patent protection?
Methyldopate hydrochloride
is the generic ingredient in two branded drugs marketed by Merck, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for methyldopate hydrochloride.
Summary for methyldopate hydrochloride
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 8 |
NDAs: | 11 |
Drug Master File Entries: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 258 |
DailyMed Link: | methyldopate hydrochloride at DailyMed |
US Patents and Regulatory Information for methyldopate hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070291-001 | Jul 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Parenteral | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 072974-001 | Nov 22, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | METHYLDOPATE HYDROCHLORIDE | methyldopate hydrochloride | INJECTABLE;INJECTION | 070698-001 | Jun 15, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Merck | ALDOMET | methyldopate hydrochloride | INJECTABLE;INJECTION | 013401-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |